标签： ditosylate

1624-100   Lapatinib Ditosylate (Tykerb, Tyverb, GW-572016)   品牌 Biovision

Lapatinib Ditosylate (Tykerb, Tyverb, GW-572016)

货号： 1624-100      产品名称： Lapatinib Ditosylate (Tykerb, Tyverb, GW-572016)   品牌： Biovision 规格： 100 mg 3周到货 生化实验

Lapatinib Ditosylate (Tykerb, Tyverb, GW-572016)
Product Overview
Product Name: Lapatinib Ditosylate (Tykerb, Tyverb, GW-572016)
Alternate Name/Synonyms: GW-57201, Tykerb, Tyverb
Description: Lapatinib is a potent inhibitor of EGFR kinase (Ki = 3 nM), ErbB-2 kinase (Ki = 13 nM), ErbB-4 kinase (Ki = 347 nM). Lapatinib can restore tamoxifen sensitivity in tamoxifen-resistant, ER-positive breast cancer models.
Peptide Sequence: N/A
Appearance: Yellow solid
Formulation: N/A
CAS Number: 388082-78-8
Molecular Formula: C₂₉H₂₆ClFN₄O₄S.2C₇H₈O₃S
Molecular Weight: 925.46
Purity: ≥99% by HPLC
Solubility:DMSO (200 mg/ml)
Storage Temp.: -20°C
Shipping Conditions: RT
Handling: Protect from air and moisture
SMILES: CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl
InChi: InChI=1S/C29H26ClFN4O4S.2C7H8O3S/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19;2*1-6-2-4-7(5-3-6)11(8,9)10/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35);2*2-5H,1H3,(H,8,9,10)
InChi Key: UWYXLGUQQFPJRI-UHFFFAOYSA-N
PubChem CID: 9941095
MDL Number: MFCD18904381
USAGE: For Research Use Only! Not For Use in Humans.

-20°C

1624-25   Lapatinib Ditosylate (Tykerb, Tyverb, GW-572016)   品牌 Biovision

Lapatinib Ditosylate (Tykerb, Tyverb, GW-572016)

货号： 1624-25      产品名称： Lapatinib Ditosylate (Tykerb, Tyverb, GW-572016)   品牌： Biovision 规格： 25 mg 3周到货 生化实验

Lapatinib Ditosylate (Tykerb, Tyverb, GW-572016)
Product Overview
Product Name: Lapatinib Ditosylate (Tykerb, Tyverb, GW-572016)
Alternate Name/Synonyms: GW-57201, Tykerb, Tyverb
Description: Lapatinib is a potent inhibitor of EGFR kinase (Ki = 3 nM), ErbB-2 kinase (Ki = 13 nM), ErbB-4 kinase (Ki = 347 nM). Lapatinib can restore tamoxifen sensitivity in tamoxifen-resistant, ER-positive breast cancer models.
Peptide Sequence: N/A
Appearance: Yellow solid
Formulation: N/A
CAS Number: 388082-78-8
Molecular Formula: C₂₉H₂₆ClFN₄O₄S.2C₇H₈O₃S
Molecular Weight: 925.46
Purity: ≥99% by HPLC
Solubility:DMSO (200 mg/ml)
Storage Temp.: -20°C
Shipping Conditions: RT
Handling: Protect from air and moisture
SMILES: CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl
InChi: InChI=1S/C29H26ClFN4O4S.2C7H8O3S/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19;2*1-6-2-4-7(5-3-6)11(8,9)10/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35);2*2-5H,1H3,(H,8,9,10)
InChi Key: UWYXLGUQQFPJRI-UHFFFAOYSA-N
PubChem CID: 9941095
MDL Number: MFCD18904381
USAGE: For Research Use Only! Not For Use in Humans.

-20°C

L0360-10 mg   Lapatinib Ditosylate   品牌 LKT

Lapatinib Ditosylate

货号： L0360-10 mg      产品名称： Lapatinib Ditosylate   品牌： LKT 规格： 10 mg 三周到货 生化试验

Lapatinib Ditosylate     
Description
A treatment FDA approved for breast cancer. It is used in patients whose cancer is HER2 positive. Used for treatment of solid tumors and is an ATP competitive epidermal growth factor and HER2 dual tyrosine kinase inhibitor.
More information about Protein Kinase Inhibitors 
Specifications 
Cas No. 388082-78-8
Product ID  L0360
Product Name  Lapatinib Ditosylate
Formula Wt. 925.46
Melting Point 236-259oC
Solubility Slightly in DMSO
Store Temp Ambient
References Feng, Yu-fei. Zhongguo Xinyao Zazhi (2007), 16(23), 1990-1993. Nelson, M. H. Therapeutics and Clinical Risk Management (2007), 3(4), 665-673.
 

室温

L0360-100 mg   Lapatinib Ditosylate   品牌 LKT

Lapatinib Ditosylate

货号： L0360-100 mg      产品名称： Lapatinib Ditosylate   品牌： LKT 规格： 100 mg 三周到货 生化试验

Lapatinib Ditosylate     
Description
A treatment FDA approved for breast cancer. It is used in patients whose cancer is HER2 positive. Used for treatment of solid tumors and is an ATP competitive epidermal growth factor and HER2 dual tyrosine kinase inhibitor.
More information about Protein Kinase Inhibitors 
Specifications 
Cas No. 388082-78-8
Product ID  L0360
Product Name  Lapatinib Ditosylate
Formula Wt. 925.46
Melting Point 236-259oC
Solubility Slightly in DMSO
Store Temp Ambient
References Feng, Yu-fei. Zhongguo Xinyao Zazhi (2007), 16(23), 1990-1993. Nelson, M. H. Therapeutics and Clinical Risk Management (2007), 3(4), 665-673.
 

室温

L0360-25 mg   Lapatinib Ditosylate   品牌 LKT

Lapatinib Ditosylate

货号： L0360-25 mg      产品名称： Lapatinib Ditosylate   品牌： LKT 规格： 25 mg 三周到货 生化试验

Lapatinib Ditosylate     
Description
A treatment FDA approved for breast cancer. It is used in patients whose cancer is HER2 positive. Used for treatment of solid tumors and is an ATP competitive epidermal growth factor and HER2 dual tyrosine kinase inhibitor.
More information about Protein Kinase Inhibitors 
Specifications 
Cas No. 388082-78-8
Product ID  L0360
Product Name  Lapatinib Ditosylate
Formula Wt. 925.46
Melting Point 236-259oC
Solubility Slightly in DMSO
Store Temp Ambient
References Feng, Yu-fei. Zhongguo Xinyao Zazhi (2007), 16(23), 1990-1993. Nelson, M. H. Therapeutics and Clinical Risk Management (2007), 3(4), 665-673.
 

室温